Saturday February 24th 2018

Biogen prevails in dispute over key Tecfidera patent

A panel of judges has upheld a key patent on Biogen ’s blockbuster multiple sclerosis treatment Tecfidera, rejecting a challenge filed by hedge fund manager Kyle Bass last year. The Patent Trial and Appeal Board on Tuesday upheld the validity of the patent, which relates to the dosage of Tecfidera’s key ingredient. Since coming onto the market i n 2013, the drug has emerged as Biogen’s biggest moneymaker, accounting for nearly $4 billion of the company’s $11.4 billion in total revenues in… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Continue reading:

Biogen prevails in dispute over key Tecfidera patent

Leave a Comment

More from category

Multiple sclerosis: Skin cells may help to repair nerve damage
Multiple sclerosis: Skin cells may help to repair nerve damage

Researchers could be on the verge of a new treatment for multiple sclerosis; they reveal how transplanting neural stem [Read More]

Medical News Today: Multiple sclerosis: Skin cells may help to repair nerve damage
Medical News Today: Multiple sclerosis: Skin cells may help to repair nerve damage

Researchers could be on the verge of a new treatment for multiple sclerosis; they reveal how transplanting neural stem [Read More]

Researchers discover how the body skillfully extinguishes inflammation
Researchers discover how the body skillfully extinguishes inflammation

Inflammation needs energy An important source for this energy is oxygen, which is indispensable for the cells of the [Read More]

MS patients who feel stigmatized more likely to suffer from depression
MS patients who feel stigmatized more likely to suffer from depression

People with Multiple Sclerosis -- MS -- who feel stigmatized are more likely to suffer from depression, according to [Read More]

Stigma increases risk of depression for people with Multiple Sclerosis
Stigma increases risk of depression for people with Multiple Sclerosis

(Penn State) People with Multiple Sclerosis -- MS -- who feel stigmatized are more likely to suffer from depression, [Read More]